Nektar Therapeutics chief R&D officer sells $336,211 in stock

Markets Investing.com By Investing.com 22 Jun 2026 16:55 1 min read

Nektar Therapeutics chief R&D officer sells $336,211 in stock

Nektar Therapeutics chief R&D officer sells $336,211 in stock

Nektar Therapeutics chief R&D officer sells $336,211 in stock

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.